DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 312 participants.
Also called NCT07241897
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 312 participants
- Registry
-
NCT07241897
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07241897. Randomized; triple masking; primary purpose treatment. Start 2025-12-15 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes
- Condition
- Ischemic Stroke
- Condition
- Diabete Mellitus
- Intervention (Drug)
- Sentagliptin Phosphate - single dose
- Intervention (Drug)
- Placebo
- Lead sponsor
- Second Affiliated Hospital of Soochow University
Record details
- Record id
cardio:ct-nct07241897- Content hash
46b4a49c9735f8bb2a282e75ebe30f2a4d2523a035db163e11c8f8e9cf7516c8